2024. Polymeric Nanoparticle-Mediated Delivery of Oncolytic Measles Virus for Targeted Therapy in Cervical Cancer. Pharmaceutical Communications. 3, 1 (Jun. 2024), 45–53. DOI:https://doi.org/10.55627/pharma.003.001.0887.